Source: DGNews  |  Posted 9 years ago

By David J.E. Candlish

NICE, FRANCE -- October 21, 2002 -- A novel combination of docetaxel, 5-fluorouracil (5-FU), and epirubicin has proved effective in the treatment of previously untreated advanced cancer, according to researchers.

In a study presented at the 27th Congress of the European Society for Medical Oncology, Dr Andre Murad of the Brazilian Gastric Cancer Study Group, Belo-Horizonte, Brazil, described the study results. The regimen has demonstrated its effectiveness in the treatment to date of 37 patients with histologically confirmed stage IIIB or IV gastric cancer, albeit with a safety profile that needs to be monitored carefully.

Patients received docetaxel (Taxotere